The Keys to Successful Digital Therapeutics Commercialization

Posted by Pete Masloski on Wed, Jan 08, 2020

One of the more exciting areas in the world of digital health is a subset of solutions known as digital therapeutics, or DTx. The Digital Therapeutics Alliance defines them as “software-based solutions used by patients and their caregivers or providers that are clinically validated where their use leads to a tangible improvement in health outcomes.” Pear Therapeutics, Propeller Health and Voluntis are a few of the pioneering companies that have introduced DTx solutions. Many DTx solutions implement an established behavioral or physical therapy with software tailored to each patient. Others use video games or virtual reality to alleviate pain or address ADHD.


>
Read More

Accelerating Market Access: Three Trends Shaping Pharma’s Future

Posted by Ed Schoonveld on Mon, Jan 06, 2020

Dean Hakanson co-wrote this blog post with Ed Schoonveld. This blog post was originally published on The Price of Global Health.

Is the demand for value-based care merely superficial? Are the industry’s decision-making and incentive systems built to encourage clinical innovation? How will pharma companies rethink their pipelines to improve poor commercialization efforts?


>
Read More

What Can J.R.R. Tolkien Teach Us About AI Adoption?

Posted by Asheesh Shukla on Wed, Dec 18, 2019

While companies are embracing AI, a recent study shows that their pursuits are driven more by fear of obsolescence than enthusiasm for change. Eighty percent of companies in a recent survey stated that they intend to expand their AI use over the next 12 months, but we also know that 77% of AI projects face challenges with business adoption, and less than 8% of companies have successfully implemented AI at the enterprise level.


>
Read More

Why Now's the Time for An Agile Marketing Transformation

Posted by Erin Liman on Tue, Dec 10, 2019

MaryAnn Godwin co-wrote this blog post with Erin Liman.

Given the significant changes in the healthcare landscape, marketers’ ways of working must evolve. Products are becoming less clinically differentiated, big data and artificial intelligence hold the promise of a customer insights renaissance and customers now expect seamless, real-time communication. In this new world of data proliferation and nonstop omnichannel intervention, a deeper, human connection is necessary to truly differentiate the customer experience.


>
Read More

Alternate Sites of Care: The Changing Face of Healthcare Delivery

Posted by Parijat Sharma on Wed, Nov 27, 2019

Matthew Ruple co-authored this post with Parijat Sharma. This is the first in a series of blog posts on the shifting sites of care. 

A confluence of factors is driving a dramatic shift in healthcare delivery from traditional sites of care such as hospitals and clinics to outpatient and retail care sites such as urgent care clinics and ambulatory surgical centers. Of course, this shift doesn’t just change things for patients and providers. It also greatly affects the go-to-market strategies for pharmaceutical and medical device manufacturers. As the care setting evolves and diversifies, stakeholders throughout the healthcare ecosystem have to evolve in kind.


>
Read More